GALT Q1 2026 Earnings WiderThanExpected Loss as ClinicalStage Biotech Continues RD Spend MDIA Q3 2023 Earnings Negative EPS Amidst Ongoing Industry Challenges Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues ATLCL Q1 2026 Earnings EPS Beat with 258 Surprise Stock Edges Up SWKHL Q3 2025 Earnings Strong EPS Beat Driven by Portfolio Performance ConocoPhillips Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Lower